FDA Inspection 871324 — DOW LAO Blood Bank
The FDA completed an inspection of DOW LAO Blood Bank on March 25, 2014 in Plaquemine, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 25, 2014
- Fiscal Year
- 2014
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Plaquemine, LA (United States)